Progesterone formulations

This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters, in particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while sti...

Full description

Saved in:
Bibliographic Details
Main Authors BERNICK Brian, THORSTEINSSON Thorsteinn, SANCILIO Frederick, PERSICANER Peter, AMADIO Julia, CACACE Janice
Format Patent
LanguageEnglish
Hebrew
Published 30.11.2016
Online AccessGet full text

Cover

More Information
Summary:This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters, in particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.
Bibliography:Application Number: IL20160247828